Antibiotic use in eastern Europe: A cross-national database study in coordination with the WHO Regional Office for Europe

The Lancet Infectious Diseases

Volumn 14, Issue 5, 2014, Pages 381-387

  Versporten, Ann ^a   Bolokhovets, Ganna ^b   Ghazaryan, Lilit ^c   Abilova, Vafa ^d   Pyshnik, Galina ^e   Spasojevic, Tijana ^f   Korinteli, Irma ^g   Raka, Lul ^h   Kambaralieva, Baktygul ⁱ   Cizmovic, Lidija ^j   Carp, Angela ^k   Radonjic, Vesela ^l   Maqsudova, Nargis ^m   Celik, Hatice Demet ⁿ   Payerl Pal, Marina ^o   Pedersen, Hanne Bak ^b   Sautenkova, Nina ^b   Goossens, Herman ^a  

^a UNIVERSITY OF ANTWERP   (Belgium)

^b WHO REGIONAL OFFICE FOR EUROPE   (Denmark)

^c Scientific Centre of Drug and Medical Technology Expertise   (Armenia)

^d Ministry of Health of Azerbaijan Republic   (Azerbaijan)

^e Ministry of Health Republic of Belarus   (Belarus)

^f Agency for Medicines and Medical Devices of Bosnia and Herzegovina   (Bosnia and Herzegovina)

^g JSC My family Clinic   (Georgia)

^h UNIVERSITY OF PRI TINA   (Serbia)

ⁱ CitiHope International   (Kyrgyzstan)

^j Agency for Medicines and Medical Devices of Montenegro   (Montenegro)

^k Agency of Medicines   (Moldova)

^l Medicines and Medical Devices Agency of Serbia   (Serbia)

^m Avicenna Tajik State Medical University   (Tajikistan)

ⁿ MINISTRY OF HEALTH   (Turkey)

^o Croatian Committee for Antibiotic Resistance Surveillance Croatian Academy for Medical Sciences   (Croatia)

more..

Author keywords

[No Author keywords available]

Indexed keywords

ANTI-BACTERIAL AGENTS; DATABASES, FACTUAL; DRUG UTILIZATION; EUROPE, EASTERN; EUROPEAN UNION; HUMANS; WORLD HEALTH ORGANIZATION;

EID: 84899430194     PISSN: 14733099     EISSN: 14744457     Source Type: Journal    
DOI: 10.1016/S1473-3099(14)70071-4     Document Type: Article

References (32)

1. Goossens H, Ferech M, Vander SR, Elseviers M Outpatient antibiotic use in Europe and association with resistance: a cross-national database study. Lancet 2005, 365:579-587.
2. Malhotra-Kumar S, Lammens C, Coenen S, Van Herck K, Goossens H Effect of azithromycin and clarithromycin therapy on pharyngeal carriage of macrolide-resistant streptococci in healthy volunteers: a randomised, double-blind, placebo-controlled study. Lancet 2007, 369:482-490.
3. Antimicrobial resistance surveillance in Europe 2011. Annual Report of the European Antimicrobial Resistance Surveillance Network (EARS-Net) 2012, ECDC, European Centre for Disease Prevention and Control, Stockholm.
4. Insight report: global risks 2013 2013, WEF, World Economic Forum, Geneva, (accessed May 22, 2013). http://www3.weforum.org/docs/WEF_GlobalRisks_Report_2013.pdf, 8th edn.
5. Gulland A Science ministers discuss the growing threat of antimicrobial resistance. BMJ 2013, 346:f3921.
6. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H European surveillance of antimicrobial consumption (ESAC): data collection performance and methodological approach. Br J Clin Pharmacol 2004, 58:419-428.
7. Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient antibiotic use in Europe (1997-2009). J Antimicrob Chemother 2011, 66(suppl 6):vi3-v12.
8. European surveillance networks/ECDC disease specific surveillance ECDC, (accessed Jan 28, 2014). http://www.ecdc.europa.eu/en/activities/surveillance/european_surveillance_networks/Pages/european_surveillance_networks.aspx.
9. Surveillance of antimicrobial consumption in Europe, 2010 2013, ECDC, European Centre for Disease Prevention and Control, Stockholm, (accessed Sept 16, 2013). http://www.ecdc.europa.eu/en/publications/Publications/antimicrobial-antibiotic-consumption-ESAC-report-2010-data.pdf.
10. Anatomical Therapeutic Chemical (ATC) classification system: guidelines for ATC classification and DDD assignment 2013, WHO, WHO Collaborating Centre for Drug Statistics Methodology, Oslo, (accessed May 14, 2013). http://www.whocc.no/atc_ddd_methodology/purpose_of_the_atc_ddd_system/.
11. Human development trends data by indicator: population, total both sexes (thousands) UNDP, (accessed Jan 28, 2014). https://data.undp.org/dataset/Population-total-both-sexes-thousands-/a6kh-7xde.
12. Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient macrolide, lincosamide and streptogramin (MLS) use in Europe (1997-2009). J Antimicrob Chemother 2011, 66(suppl 6):vi37-vi45.
13. Adriaenssens N, Coenen S, Versporten A, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient quinolone use in Europe (1997-2009). J Antimicrob Chemother 2011, 66(suppl 6):vi47-vi56.
14. ESAC-Net interactive database ECDC, (accessed Feb 25, 2014). http://www.ecdc.europa.eu/en/healthtopics/antimicrobial_resistance/esac-net-database/Pages/database.aspx.
15. Tonoyan T, Muradyan L Health inequalities in Armenia-analysis of survey results. Int J Equity Health 2012, 11:32.
16. Balabanova D, McKee M, Pomerleau J, Rose R, Haerpfer C Health service utilization in the former Soviet Union: evidence from eight countries. Health Serv Res 2004, 39:1927-1950.
17. Campos J, Ferech M, Lazaro E, et al. Surveillance of outpatient antibiotic consumption in Spain according to sales data and reimbursement data. J Antimicrob Chemother 2007, 60:698-701.
18. Clark DV, Ismayilov A, Bakhishova S, et al. Under-utilization of health care services for infectious diseases syndromes in rural Azerbaijan: a cross-sectional study. BMC Health Serv Res 2011, 11:32.
19. Rabin AS, Kuchukhidze G, Sanikidze E, Kempker RR, Blumberg HM Prescribed and self-medication use increase delays in diagnosis of tuberculosis in the country of Georgia. Int J Tuberc Lung Dis 2013, 17:214-220.
20. Joint annual review meeting on national health strategy of Tajikistan WHO Europe, (accessed Jan 28, 2014). http://www.euro.who.int/en/countries/tajikistan/news/news/2011/11/joint-annual-review-meeting-on-national-health-strategy-of-tajikistan.
21. Huttner B, Goossens H, Verheij T, Harbarth S Characteristics and outcomes of public campaigns aimed at improving the use of antibiotics in outpatients in high-income countries. Lancet Infect Dis 2010, 10:17-31.
22. Woodhead M, Blasi F, Ewig S, et al. Guidelines for the management of adult lower respiratory tract infections. Eur Respir J 2005, 26:1138-1180.
23. Butler CC, Hood K, Verheij T, et al. Variation in antibiotic prescribing and its impact on recovery in patients with acute cough in primary care: prospective study in 13 countries. BMJ 2009, 338:b2242.
24. Little P, Stuart B, Moore M, et al. Amoxicillin for acute lower-respiratory-tract infection in primary care when pneumonia is not suspected: a 12-country, randomised, placebo-controlled trial. Lancet Infect Dis 2013, 13:123-129.
25. Versporten A, Coenen S, Adriaenssens N, et al. European Surveillance of Antimicrobial Consumption (ESAC): outpatient cephalosporin use in Europe (1997-2009). J Antimicrob Chemother 2011, 66(suppl 6):vi25-vi35.
26. Guglielmo BJ Chapter e1: anti-infective chemotherapeutic and antibiotic agents. Current Medical Diagnosis and Treatment 2013 2013, McGraw-Hill, New York, NY. M.A. Papadakis, S.J. McPhee, M.W. Rabow (Eds.).
27. Livermore DM, Hawkey PM CTX-M: changing the face of ESBLs in the UK. J Antimicrob Chemother 2005, 56:451-454.
28. Coenen S, Muller A, Adriaenssens N, Vankerckhoven V, Hendrickx E, Goossens H European Surveillance of Antimicrobial Consumption (ESAC): outpatient parenteral antibiotic treatment in Europe. J Antimicrob Chemother 2009, 64:200-205.
29. Vander Stichele RH, Elseviers MM, Ferech M, Blot S, Goossens H Hospital consumption of antibiotics in 15 European countries: results of the ESAC Retrospective Data Collection (1997-2002). J Antimicrob Chemother 2006, 58:159-167.
30. Esposito S, Noviello S, Leone S, et al. Outpatient parenteral antibiotic therapy (OPAT) in different countries: a comparison. Int J Antimicrob Agents 2004, 24:473-478.
31. Goossens H, Guillemot D, Ferech M, et al. National campaigns to improve antibiotic use. Eur J Clin Pharmacol 2006, 62:373-379.
32. Coenen S, Ferech M, Haaijer-Ruskamp FM, et al. European Surveillance of Antimicrobial Consumption (ESAC): quality indicators for outpatient antibiotic use in Europe. Qual Saf Health Care 2007, 16:440-445.